期刊文献+

超敏C反应蛋白和血管性假性血友病因子对高血压合并颈动脉粥样硬化的诊断价值 被引量:4

Diagnostic value of high-sensitivity C-reactive protein(hs-CRP) and von Willebrand factor(vWF) in carotid atherosclerosis in essential hypertension patients
下载PDF
导出
摘要 目的研究血清超敏C反应蛋白(high-sensitivity C-reactive protein,hs-CRP)和血管性假性血友病因子(vonWillebrand factor,vWF)与高血压患者合并颈动脉粥样硬化发生的关系。方法对入选的148例高血压患者进行颈动脉超声检查测量颈总动脉内膜中层厚度(IMT)、观察有无斑块形成,并分为颈动脉正常组(42例)、颈动脉增厚组(83例)和颈动脉斑块组(23例),分别检测血清超敏C反应蛋白、假性血友病因子和血脂指标,进行组间比较。并把hsCRP、vWF分别与年龄、收缩压、脉压和高血压危险度分层进行相关性分析。结果 hsCRP在颈动脉正常组与颈动脉斑块组间有显著差异(P<0.01);vWF在颈动脉正常组与颈动脉斑块组间有显著差异(P<0.05)。hsCRP与年龄有显著性相关,vWF与年龄、脉压和高血压危险度有相关性。hsCRP与vWF具有相关性。结论 hsCRP和vWF都与动脉粥样硬化的发生相关。 Objective To study the relationship between high-sensitivity C-reactive protein(hs-CRP) / von Willebrand factor(vWF) and carotid atherosclerosis in essential hypertension patients.Methods With the help of ultrasound,83 cases of increased intima-media thickness of carotid artery,23 of atheromatous plaque formation and 42 of normal arteries were noted in 148 cases of essential hypertension.Serum hs-CRP,vWF and blood lipid were examined in these cases and analysed together with the factors of age,systolic pressure and hypertension criticality.Results In comparison with the normal carotid artery group,serum hs-CRP(P〈0.01) and vWF(P〈0.05)were significantly higher in the arteriosclerosis group,whilst hs-CRP was correlated with age and vWF with age,systolic pressure and hypertension criticality.Conclusion Serum hs-CRP and vWF are associated with carotid atherosclerosis.
出处 《中国实验诊断学》 北大核心 2010年第7期1070-1072,共3页 Chinese Journal of Laboratory Diagnosis
关键词 超敏C反应蛋白 血管性假性血友病因子 颈动脉粥样硬化 high-sensitivity C-reactive protein von Willebrand factor carotid atherosclerosis
  • 相关文献

参考文献7

  • 1Schumacher A,Seljeflot I,Sommervoll L,et al.Increased lecels of endothelial haemostatic markers in patients with coronary heart disease[J].Thromb Res,2002,105(1):25.
  • 2European Society of Hypertinsion-European Society of Cardiology Guidelines Committee.2003 European Society of Hypertension-European Society of Cardiology Guidelines for the management of arterial hypertension[J].J Hypertens,2003,21:1011.
  • 3王瑞英,任军梅.原发性高血压和心力衰竭患者血浆肾上腺髓质素和高敏C反应蛋白变化的研究[J].中华老年心脑血管病杂志,2006,8(2):79-81. 被引量:5
  • 4Haidari M,Javadi E.Evaluation of C-reaction protein,a sensitive maker of inflammation,as a risk factor for stalble coronary disease.Clin Biochem,2001,33:309.
  • 5Lim HS,Lip GY,Blann AD,et al.Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension[J].J Clin Endocrinol Metab,2004,89(11):5377.
  • 6Clapp B,Hingorani A,Kharbanda R,et al.Inflammation induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress[J].Cardiovasc Res,2004,64:172.
  • 7全国血压抽样调查协作组.中国人群高血压患病率及其变化趋势[J].高血压杂志,1995,3(A01):7-13. 被引量:508

二级参考文献13

  • 1曹剑,李小鹰,范利,朱冰坡,刘涛.老年高血压病并下肢动脉硬化症的血管内皮功能[J].中华老年心脑血管病杂志,2005,7(5):317-319. 被引量:4
  • 2Caliumi C, Cianci R, Celi M, et al. Plasma adrenomedullin concentrations in patients with renovascular or malignant hypertension [ J].Minerva Cardioangiol, 2004,52 : 313-322.
  • 3Savoia C, Schiffrin EL. Significance of recently identified peptides in hypertension: endothelin, natriuretic peptides, adrenomedullin, leptin[ J]. Med Clin North Am, 2004,88 : 39-62.
  • 4Kitamura C, Kangawa K, Kawamoto M, et al. Adrenomedullin: a novel hypotensive peptide isolated from homan pheochromocytoma[J].Biochem Biolphys Res Commu, 1993, 199:553-560.
  • 5Ichiki Y, Kitamura, Kangana K, et al. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma[J].FEBS lett, 1994,338:6-10.
  • 6Sugo S, Minamino N, Kangana K, et al. Endothelial cells actively synthesize and secrete adrenomedullin [ J ].Biochem Biophys Res Commun, 1994,201 : 1160-1166.
  • 7Nicholls MG, Charles CJ,Lainchbury JG, et al. Adrenomedullin in heart failure[J]. Hypertens Res,2003,26(Suppl 1 ) :35-40.
  • 8Petrie MC, Hillier C, Johnston F, et al. Effect of neutral endopeptidase inhibition on the actions of adrenomedullin and endothelin-1 in resistance arteries from patients with chronic heart failure[J]. Hypertension, 2001,38:412-416.
  • 9Gabay C, Kushner I. Acute-phase proteins and other systemic response to inflammation[J]. N Engl J Med, 1999,340:448-454.
  • 10Fichtlscherer S, Rosenberer G, Dirk H, et al. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease[J]. Circulation ,2000,102:1000-1006.

共引文献511

同被引文献39

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部